Broker Recommendations
Canaccord Genuity hikes target price on Cerillion
Analysts at Canaccord Genuity hiked their target price on software firm Cerillion from 1,675. 0p to 2,000. 0p on Monday following the group's FY24 trading update.
JPMorgan stays positive about Future despite CEO exit
Future’s share price took a dive last week after the unexpected departure of chief executive Jon Steinberg, but the news didn’t dissuade JPMorgan from changing its positive view on the publishing and events company.
RBC Capital downgrades Intertek to ‘sector perform’
RBC Capital Markets downgraded Intertek on Monday to ‘sector perform’ from ‘outperform’ and cut the price target to 5,000p from 5,200p.
Berenberg lowers target price on Rio Tinto
Analysts at Berenberg lowered their target price on mining giant Rio Tinto from 6,200. 0p to 6,000. 0p on Friday following the group's Q3 operational review.
Citi downgrades Bunzl to 'neutral' from 'buy'
Citi downgraded Bunzl on Friday to ‘neutral’ from ‘buy’ after a run-up in the shares, but kept its 3,700p price target.
Berenberg slightly raises target price on Quilter
Analysts at Berenberg slightly raised their target price on wealth management firm Quilter from 135. 0p to 140. 0p on Thursday, stating Q3 had been "a stellar quarter" for flows.
Canaccord Genuity downgrades Plus500 to 'hold'
Analysts at Canaccord Genuity downgraded capital markets business Plus500 from 'speculative buy' to 'hold' on Thursday but hiked their target price on the stock from 1,883. 0p to 2,650. 0p ahead of the group's Q3 trading update on 28 October.
Canaccord Genuity lowers target price on On The Beach
Canaccord Genuity lowered its target price on packaged holidays business On The Beach from 220. 0p to 187. 0p following the group's recent trading update.
Berenberg raises target price on Bellway following FY24 earnings
Analysts at Berenberg raised their target price on housebuilder Bellway from 2,900. 0p to 3,200. 0p on Wednesday following the group's FY24 earnings a day earlier.
RBC upgrades Bodycote after recent share-price slump
RBC Capital Markets has upgraded its rating Bodycote following recent weakness in the share price, saying that the stock looks "attractive value" in spite of end-market headwinds.
Jefferies upgrades NatWest to 'buy' but prefers Lloyds
Jefferies has upgraded its recommendation for NatWest from 'underperform' to 'buy', but still rates Lloyds as its preferred stock in the UK banking sector.
Berenberg lowers target price on National Grid
Analysts at Berenberg lowered their target price on utilities giant National Grid from 1,150. 0p to 1,070. 0p on Tuesday, stating the group would now be forced to deliver "a balancing act".
RBC stays positive about JD Sports on improving global footprint
JD Sports Fashion's share price has fallen sharply in the wake of the retailer's interim results two weeks ago, but RBC Capital Markets has reiterated its 'outperform' rating, saying that the stock's valuation still remains "undemanding".
JPMorgan upgrades Bunzl to 'overweight'
JPMorgan Cazenove upgraded Bunzl on Monday to ‘overweight’ from ‘neutral’ and lifted the price target to 3,980p from 3,660p as it increased its medium-term underlying margin assumptions to reflect greater confidence in a positive trajectory.
Auction Technology Group performing well but improvements needed, says RBC
RBC Capital Markets has trimmed its target price for Auction Technology Group (ATG) and kept a 'sector perform' stance on the stock, saying that it needs to see evidence of improving market conditions before turning more positive.
Stifel upgrades Barratt Redrow, Crest Nicholson
Stifel adjusted its ratings on several UK housebuilders on Friday, upgrading Barratt Redrow and Crest Nicholson to ‘buy’ from ‘hold’ on the back of underperformance and a compelling valuation, respectively.
JPMorgan downgrades Vistry, sees little scope for outperformance
JPMorgan Cazenove has cut its recommendation for Vistry from 'overweight' to 'neutral' and slashed its target price more than a third after a profit warning from the housebuilder on Tuesday, saying that the company needs to "restore confidence" among investors.
Broker tips: GSK, Central Asia Metals
GSK's $2. 2bn payment to settle 93% of outstanding Zantac lawsuits in the US was close to the "best case scenario", according to Jefferies, which said the announcement should remove a significant weight on the share price.
Berenberg dowgrades Central Asia Metals to 'hold'
Analysts at Berenberg downgraded Central Asia Metals from 'buy' to 'hold' on Thursday and lowered its target price on the stock from 230. 0p to 210. 0p following the group's Q3 production results a day earlier.
GSK's Zantac settlement should give stock a boost, says Jefferies
GSK's $2. 2bn payment to settle 93% of outstanding Zantac lawsuits in the US was close to the "best case scenario", according to Jefferies, which said the announcement should remove a significant weight on the share price.